Video

A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

Author(s):

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.

The approximately 350 year-round residents of Swan’s Island, a small island near Acadia National Park off the coast of Maine, have received routine medical care from the Mill Pond Health Center for the last 13 years. And although the new coronavirus pandemic, also known as COVID-19, has altered how people receive health care everywhere, the health center’s director — a patient with cancer herself – tells CURE® that it will stay open and continue to provide care for as long as it can.

CURE® spoke with Donna Wiegle, a survivor of cervical cancer who is currently battling ovarian cancer, about her cancer journey as well as the precautions the center is taking to ensure the safety of its patients. Additionally, Wiegle offers insight into why, even as she may be at more risk for the virus as a patient with cancer, she has not decided to close the island’s only health center.

“I've given this a lot of thought about my own risk to stay working, because this is entirely my decision,” she said. “I recognize that we need health services that other communities have readily available to them. What we have is very minimal to begin with … (and) I feel that my community has come to depend on me over all these years and I don't want to let them down.”

Related Videos
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.